LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

CT Scan Casts Doubt on Hominid Child’s Brain Development Is Similar to That of Modern Humans

By LabMedica International staff writers
Posted on 01 Sep 2014
Image: The Taung Child fossil at the Evolutionary Studies Institute at Wits University (Photo courtesy of Wits University).
Image: The Taung Child fossil at the Evolutionary Studies Institute at Wits University (Photo courtesy of Wits University).
Image: The Taung Child fossil at the Evolutionary Studies Institute at Wits University (Photo courtesy of Wits University).
Image: The Taung Child fossil at the Evolutionary Studies Institute at Wits University (Photo courtesy of Wits University).
By undergoing advanced computed tomography (CT) scanning, the skull of the famous fossil child is providing evidence for researchers against the human evolutionary hypotheses that the hominid Australopithecus africanus shows the same cranial adaptations found in modern human infants and toddlers.

The Taung Child, South Africa’s most important hominid fossil remains discovered 90 years ago by Wits University Prof. Raymond Dart, is providing major insights into human origins. By subjecting the skull of the first australopith discovered to the latest technologies in the University of the Witwatersrand Microfocus X-ray Computed Tomography (Johannesburg, South Africa) facility, researchers are refuting current backing for the hypothesis that this early hominid exhibits infant brain development in the prefrontal region similar to that of modern humans.

The findings have been published online on August 25, 2014, in the Proceedings of the National Academy of Sciences of the United States of America (PNAS). The Taung Child has historic and scientific significance in the fossil record as the first and best instance of early hominid brain evolution, and theories have been presented that it offers key cranial adaptations seen in modern human infants and toddlers.

To assess the precise age of this evolutionary adaptation, Dr. Kristian J. Carlson, senior researcher from the Evolutionary Studies Institute at the University of the Witwatersrand, and colleagues, Prof. Ralph L. Holloway from Columbia University (New York, NY, USA) and Douglas C. Broadfield from Florida Atlantic University (Boca Raton, USA), performed an in silico dissection of the Taung fossil using high-resolution CT imaging.

“A recent study has described the roughly three million-year-old fossil, thought to have belonged to a three- to four-year-old, as having a persistent metopic suture and open anterior fontanelle, two features that facilitate post-natal brain growth in human infants when their disappearance is delayed,” said Dr. Carlson.

Comparisons with the existing hominid fossil record and chimpanzee variation do not support this evolutionary scenario. Mentioning flaws in how the Taung fossil material has been recently assessed, the researchers suggest physical evidence does not incontrovertibly link characteristics of the Taung skull, or its endocast, to early prefrontal lobe expansion, a brain region associated with many human behaviors.

The scientists also argued against the earlier proposed theoretical foundation for this adaptation in A. africanus. By refuting the presence of these features in the Taung Child, the researchers dispute whether these structures were selectively beneficial in hominid evolution, especially in australopith hominids.

Therefore, study’s findings revealed that there is still no evidence for this sort of skull adaptation that evolved before modern man, neither is there evidence for a link between such skull characteristics and the suggested accompanying early prefrontal lobe expansion, according to Dr. Carlson.

Related Links:

University of the Witwatersrand Microfocus X-ray Computed Tomography Facility
Columbia University
Florida Atlantic University


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more